Company profile

Michael R. Feldschuh
Incorporated in
Fiscal year end
IRS number

DXR stock data

FINRA relative short interest over last month (20 trading days) ?


28 Mar 12
5 Jun 20
31 Dec 20


Company financial data Financial data

Quarter (USD) Dec 11 Sep 11 Dec 10 Sep 10
Revenue 369.83K 340.91K 361.37K 453.28K
Net income -1.49M -4.18M 2.27M 2.6M
Diluted EPS -0.35 -0.99 0.53 0.62
Net profit margin -403% -1227% 627% 575%
Operating income -1.01M -1.26M -1.53M -1.28M
Net change in cash 29.91K -28.03K -49.3K
Cash on hand 59.63K 29.71K 57.74K 107.04K
Cost of revenue 176.95K 149.38K 184.72K 185.74K
Annual (USD) Dec 11 Dec 10
Revenue 1.45M 1.58M
Net income -7.19M 4.97M
Diluted EPS -1.7 1.17
Net profit margin -497% 315%
Operating income -5.79M -5.66M
Net change in cash 1.88K
Cash on hand 59.63K 57.74K
Cost of revenue 652.51K 727.65K

Financial data from Daxor earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
21 Mar 19 Michael Richard Feldschuh Common Stock Buy Aquire P 12.2 200 2.44K 154,006
21 Mar 19 Michael Richard Feldschuh Common Stock Buy Aquire P 12.4 400 4.96K 153,806
21 Mar 19 Michael Richard Feldschuh Common Stock Buy Aquire P 12.3629 600 7.42K 153,406
0.5% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 5 4 +25.0%
Opened positions 1 0 +Infinity%
Closed positions 0 1 -100.0%
Increased positions 0 1 -100.0%
Reduced positions 1 1
13F shares
Current Prev Q Change
Total value 186K 198K -6.1%
Total shares 19.74K 20.51K -3.7%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Renaissance Technologies 11.1K $104K 0.0%
Prelude Capital Management 7.1K $67K -21.3%
UBS UBS 1.16K $11K NEW
WFC Wells Fargo & Co. 392 $4K 0.0%
Proequities 0 $0
Largest transactions
Shares Bought/sold Change
Prelude Capital Management 7.1K -1.92K -21.3%
UBS UBS 1.16K +1.16K NEW
WFC Wells Fargo & Co. 392 0 0.0%
Proequities 0 0
Renaissance Technologies 11.1K 0 0.0%
Content analysis ?
8th grade Avg
New words: abdomen, accident, ailure, amputee, andM, Apple, arisen, assigned, bad, bio, byA, calibrated, calibration, capillary, capture, channel, check, chomated, cold, counter, cycle, daily, Database, dehydrated, diffusion, diminished, disruption, eartF, easily, easured, enclosed, EVERESTStudy, exact, external, fabrication, factthat, FAST, filtered, Fukishima, hidden, inH, InHypertension, intake, internationally, inThe, Intuitive, invalid, Jehovah, journalAnesthesia, journalShock, knee, LEU, linearity, Literature, liver, logging, lymphatic, machine, maintenance, mental, Metropolitan, module, muscle, Netflix, nonowner, Notification, notified, ofAnesthesia, ofSEC, ofThe, Operationsfor, Paducah, parallel, petition, pituitary, plant, polar, Portsmouth, quantity, raioisotope, reatment, recycled, remote, retention, Rockville, Roosevelt, Samsca, secretion, shortly, shutdown, Simon, sodium, Solar, spite, ssessment, stable, stemming, substance, suspect, swelling, textbookCritical, theHawaii, toE, Tolvaptan, tourniquet, tsunami, underutilized, urine, warning, wasting, withdrawn, wording
Removed: Abnormal, accidentally, Agranovsky, amounted, automate, Bayside, Burn, contamination, detail, discontinued, dose, Dt, Elena, eligible, elimination, Elmhurst, emphasize, feasible, field, flowing, format, GFR, Glomeril, Hematology, identification, introducing, Manager, Mitchell, needle, owed, progressing, radioactive, receipt, refinancing, Saltzberg, spend, stick, stuck, sum, Taglich, taxed, Unaudited, vice, vital, Wilmington, Wipe